Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,536 shares at $305.38 ($1.1M) on 2023-03-24, disclosed to the SEC on 2023-03-28.
Scheduled sale ($1.1M) by EVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $305.38 | 1,768 | $540K | 50.0% |
| 2 | $305.38 | 1,768 | $540K | 50.0% |
| Total | $305.38 avg | 3,536 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-06-05 | $1.5M | — | Filing → |